市場調查報告書

全球免疫沉澱測試市場:成長,趨勢,及預測(2020年∼2025年)

Immunoprecipitation Testing Market - Growth, Trends, and Forecast (2020 - 2025)

出版商 Mordor Intelligence LLP 商品編碼 921901
出版日期 內容資訊 英文 113 Pages
商品交期: 2-3個工作天內
價格
全球免疫沉澱測試市場:成長,趨勢,及預測(2020年∼2025年) Immunoprecipitation Testing Market - Growth, Trends, and Forecast (2020 - 2025)
出版日期: 2020年01月01日內容資訊: 英文 113 Pages
簡介

帶動全球免疫沉澱測試市場成長的主要原因,是需要抗體-抗原相互作用檢驗的免疫學病例的盛行率上升。再加上為了實施下一代的DNA定序及基因學相關研究的政府、非官方機構的資金增加, 來自的及中樞神經障礙,促進著癌症,及心血管疾病的免疫沉澱實驗的用途擴大等,該市場的成長。但,為了樣本大小的限制,脂質含有量的變動等的免疫沉澱實驗的規定的使用被妨礙,有阻礙市場成長的可能性。

本報告提供全球免疫沉澱測試市場的相關調查,市場機會和趨勢,成長及阻礙因素,各類型、產品、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 生命科學的研究開發活動的增加
    • 識別自體免疫疾病相關的抗原的必要性高漲
  • 市場阻礙因素
    • 替代手法的可用性
  • 波特的五力分析

第5章 市場區隔

  • 各類型
    • 各個蛋白質的免疫沉澱
    • 共免疫沉澱(Co-IP)
    • 染色質免疫沉澱(ChIP)
    • RNA免疫沉澱(RIP)
    • 其他
  • 各產品
    • 套件
    • 試劑
  • 各終端用戶
    • 製藥及生物科技產業
    • 受託研究機構(CRO)
    • 學術研究機關
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Thermo Fisher Scientific
    • Abcam
    • BioLegend
    • Bio-Rad Laboratories
    • Biologics International Corp
    • Creative Proteomics
    • GenScript
    • Merck KGaA
    • Novus Biologicals
    • TaKaRa BIO株式會社

第7章 市場機會及今後趨勢

目錄
Product Code: 67419

Market Overview

The major factor driving the growth of the Immunoprecipitation Testing market is the rise in the prevalence of the immunology cases which requires antibody-antigen interaction testing. Furthermore, increasing funding from the government and non-government organizations to carry out researches on next-generation DNA sequencing and genomics is fuelling the market growth. Along with that, the growing applications of Immunoprecipitation Testing in central nervous disorders, cancers, and cardiovascular diseases are also boosting the growth of the Immunoprecipitation Testing market.

For instance, in 2019, Merck & Co. Inc. announced that it is going to establish a new life science hub focusing on areas such as oncology, immunology, and immuno-oncology. However, few constraints of Immunoprecipitation Testing such as limitations in sample size, variations in lipid content might hamper the usage of this test which is expected to impede the market growth.

Scope of the Report

As per the scope of this report, Immunoprecipitation (IP) is a precipitation procedure which purifies and enriches the selected protein, by allowing the identification of protein-protein interactions in proteomics workflows. IP is a vital technique used to investigate the presence, size, downregulation or up-regulation, relative abundance, post-translational modifications (PTMs), stability and interactions between proteins.

Key Market Trends

Chromatin immunoprecipitation (ChIP) segment holds significant market share

  • Chromatin Immunoprecipitation (ChIP) is a type of immunoprecipitation technique that is used to investigate the regions of the genome associated with target DNA-binding protein, or on the other hand to identify the specific proteins that are associated with a specific region of the genome. Chromatin Immunoprecipitation is commonly used in epigenetics research.
  • ChIP is expected to experience significant growth owing to technological advances. For instance, Chromatrap technology enables the accuracy of data and delivers quick results without any pipetting risks which allow researchers to simultaneously analyze multiple antibodies and gene targets.
  • Furthermore, key market players are focusing on various market strategies such as new product launches, geographical expansions, mergers and acquisitions, partnerships. For instance, In 2014, Porvair Sciences developed a new ChIP-sequencing assay kit extending the benefits of their proprietary Chromatrap solid-state ChIP technology to the preparation of purified Chromatin for the generation of sequencing libraries.
  • Hence, the overall applications of ChIP and the new product launches indicate that this segment will have a considerable share in the market.

Asia is the fastest-growing region in the Global Immunoprecipitation Testing Market

Asia-Pacific is expected to be the fastest-growing region in the Global Immunoprecipitation Testing market owing to the increasing investments and funding from the governments especially in biotechnology research, and growing awareness regarding personalized medicine. Additionally, growing collaborations and partnerships between organizations and universities are emerging in this region.

The North American region holds the largest share in the market globally. By supporting genomics research, various government bodies, like NHGRI (National Human Genome Research Institute), have supported the work on sequencing of the human genome, and fund research on the genome's structure, function, and role in health and disease.

Competitive Landscape

The immunoprecipitation Testing market has rapidly evolved over the last few years. Industry observed significant changes in adopting market strategies such as product developments, mergers, and acquisitions in recent years. Thus, the Immunoprecipitation Testing market has become a very competitive industry. Key developments in the market are Abbkine launched Agarose/Magnetic beads Conjugated Tag Antibodies, facilitating a rapid and simple tagged protein immunoprecipitation process in 2018.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Research and Development Activities in Life-sciences
    • 4.2.2 Increasing Need to Identify Antigens Associated With Autoimmune Diseases
  • 4.3 Market Restraints
    • 4.3.1 Availability of Alteranative Techniques
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Individual protein immunoprecipitation
    • 5.1.2 Co-Immunoprecipitation (Co-IP)
    • 5.1.3 Chromatin Immunoprecipitation (ChIP)
    • 5.1.4 RNA Immunoprecipitation (RIP)
    • 5.1.5 Others
  • 5.2 By Product
    • 5.2.1 Kits
    • 5.2.2 Reagents
  • 5.3 By End Users
    • 5.3.1 Pharmaceutical and Biotechnology Industries
    • 5.3.2 Contract Research Organizations (CRO's)
    • 5.3.3 Academic & Research Institutes
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Thermo Fisher Scientific
    • 6.1.2 Abcam
    • 6.1.3 BioLegend
    • 6.1.4 Bio-Rad Laboratories
    • 6.1.5 Biologics International Corp
    • 6.1.6 Creative Proteomics
    • 6.1.7 GenScript
    • 6.1.8 Merck KGaA
    • 6.1.9 Novus Biologicals
    • 6.1.10 Takara Bio

7 MARKET OPPORTUNITIES AND FUTURE TRENDS